Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Metabolic changes are observed in early and late stages of Pancreatic Neuroendocrine Tumors (PanNET) in mouse models. In human PanNET, RNA-expression analysis showed changes in glucose metabolism in more aggressive PanNET.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Bräutigam K
Authors: Straub J, Bräutigam K, Di Domenico A, Galván J, Maire R,
Keywords: metabolism, microadenoma, immunohistochemistry, pancreas, tumor, mct4, relapse,
#1928 Pancreatic Involvement in VHL Disease: The Turin Experience
Introduction: Von Hippel-Lindau disease (VHL) is a rare heritable genetic syndrome. Its typical manifestations concern CNS but it may affect other organs such as the pancreas.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Cortegoso Valdivia P
Authors: Cortegoso Valdivia P, Venezia L, De Angelis C,
Keywords: VHL,
Introduction: Von Hippel-Lindau disease (VHL) is an inherited neoplastic syndrome: pancreatic lesions in 35-77% of cases, usually serous cystic adenoma (SCA), but 5-17% are non-functioning (NF) NeuroEndocrine tumors (NETs).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Milanetto A, Liço V, Alaggio R, Pedrazzoli S, Pasquali C,
Keywords: Von Hippel-Lindau disease, NeuroEndocrine Tumor, Sunitinib,
Introduction: 8-20% of patients with VHLD develop PNETs. However, there are no markers for PNETs progression in VHLD patients. The type of mutation in VHL gene is associated with clinical phenotype of VHLD.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Tirosh A
Authors: Tirosh A, Shell J, Keutgen X, Sadowski S, Green P,
Introduction: Pancreatic neuroendocrine tumours (PNETs) occur at a higher frequency and at a younger age in patients with certain genetic conditions e.g. Von Hippel Lindau and Multiple Endocrine Neoplasia type 1. Screening for early detection and monitoring growth rates of PNETs in these high risk patients is vital in their management. MRI has emerged as the gold standard for imaging the pancreas for the detection of PNETs and diffusion weighted imaging (DWI) has become an invaluable adjunct.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: